carbon monoxide has been researched along with simvastatin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Geng, B; Tang, CS; Wu, XS; Yao, HM; Zhang, J | 1 |
Ahmad, S; Ahmed, A; Al-Ani, B; Cudmore, MJ; Fujisawa, T; Hewett, PW; Hollenberg, MD; Jayaraman, PS; Ohba, M; Ramma, W; Saifeddine, M; Sissaoui, S; Williams, H | 1 |
2 other study(ies) available for carbon monoxide and simvastatin
Article | Year |
---|---|
[Simvastatin inhibits hypertension-induced cardiac hypertrophy in rats through activation of heme oxygenase-1/carbon monoxide pathway].
Topics: Angiotensins; Animals; Carbon Monoxide; Cardiomegaly; Cell Enlargement; Heme Oxygenase-1; Hypertension; Male; Myocytes, Cardiac; Rats; Rats, Wistar; Signal Transduction; Simvastatin | 2006 |
Activation of proteinase-activated receptor 2 stimulates soluble vascular endothelial growth factor receptor 1 release via epidermal growth factor receptor transactivation in endothelial cells.
Topics: Carbon Monoxide; Cells, Cultured; Down-Regulation; Endothelial Cells; ErbB Receptors; Factor Xa; Female; Gene Expression; Heme Oxygenase-1; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; MAP Kinase Signaling System; Pre-Eclampsia; Pregnancy; Protein Kinase C; Proto-Oncogene Proteins pp60(c-src); Receptor, PAR-2; Simvastatin; Solubility; Umbilical Veins; Vascular Endothelial Growth Factor Receptor-1 | 2010 |